International Drug Discovery is the leading review of business and technology for the drug discovery arena across the globe. Each issue offers International Drug Discovery’s 20,000 readers unbiased editorial on the following topics: gene expression, laboratory automation, stem cells, HTS, HCS, HCA, translational medicine, biomarkers, flow cytometry, next generation sequencing, imaging, neuroscience, RNA based technologies, qPCR, epigenetics and much more! With its cross-border perspective, International Drug Discovery is able to keep its readership of senior executives, technical personnel, scientists, and others fully abreast of the latest trends and developments in the process of drug discovery.
Issuance
International Drug Discovery is published bi-monthly in December/January, February/March, April/May, June/July, August/September, and October/November. Each issue reaches over 20,000 key decision makers for the drug discovery arena around the world.